AlphaSense is a market intelligence and search platform used by the world’s leading companies and financial institutions. Since 2011, our AI-based technology has helped professionals make smarter business decisions by delivering insights from an extensive universe of public and private content—including company filings, event transcripts, expert calls, news, trade journals, and equity research. Our platform is trusted by over 3,500 enterprise customers, including a majority of the S&P 500. Headquartered in New York City, AlphaSense employs over 1,000 people across offices in the U.S., U.K., Germany, Finland, and India. For more information, please visit www.alpha-sense.com. | The world’s most sophisticated companies rely on AlphaSense to remove uncertainty from decision-making. With market intelligence and search built on proven AI, AlphaSense delivers insights that matter from content you can trust. Our universe of public and private content includes equity research, company filings, event transcripts, expert calls, news, trade journals, and clients’ own research content. Founded in 2011, AlphaSense is headquartered in New York City with over 1,000 people across the globe and offices in the U.S., U.K., Finland, India, and Singapore. For more information, please visit www.alpha-sense.com. | AlphaSense is how the world’s most sophisticated companies remove uncertainty from their decision-making. With market intelligence and search built on proven AI, AlphaSense quickly delivers relevant insights from a trustworthy universe of public and private content—including equity research, company filings, event transcripts, expert calls, news, trade journals, and clients’ own research content. Headquartered in New York City, AlphaSense employs over 1,000 people across offices in the U.S., U.K., Finland, India, and Singapore. For more information, please visit www.alpha-sense.com. | AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents — including equity research, earnings calls, expert interviews, filings, news, and internal proprietary content. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows with high quality outputs. With AI solutions like Generative Search, Generative Grid, and Deep Research, AlphaSense delivers the clarity and depth professionals need to navigate complexity and obtain accurate, real-time information quickly. For more information, visit www.alpha-sense.com. | AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows.
Agno Pharma
Agno Pharmaceuticals is a global small molecule CDMO supplying critical regulatory starting materials (RSMs) intermediates, active pharmaceutical ingredients (APIs) and finished dose formulations (oral, injectable & devices). Our capabilities include the manufacturing and handling of highly potent APIs, sterile APIs, water insoluble sterile drug product formulations (spry drying, nanomilling), long acting injectables, drug eluting and implantable devices to biotech, pharmaceutical, generic partners. Our expertise and excellent regulatory track record supports our sponsors from early drug development and process chemistry optimization through to large scale commercial stage cGMP manufacturing. | Your Premier Global End-To-End CDMO Purer Solutions for a Better Life ! Unlocking the potential of pharmaceutical innovation, Agno Pharmaceuticals offers comprehensive solutions spanning from critical API development to sterile drug product formulation to cGMP manufacturing for clinical trials to commercial production of APIs, Chemical Intermediates, Regulatory Starting Materials, and Drug Product. With a track record of excellence and cutting-edge facilities, we specialize in tailored services for clients worldwide, delivering quality solutions for over 20 years. With cutting-edge facilities, seasoned experts, and a commitment to excellence, we provide tailored services across the drug development spectrum, ensuring superior quality and compliance from preclinical to commercialization.
AGMI Group
AGMI Group is a global advisory and execution firm specializing in strategy and operations for life sciences and healthcare companies. With deep roots in biopharma, medtech, and diagnostics, we partner with industry leaders, venture-backed innovators, and private capital to drive value across R&D, commercialization, and investment cycles. Founded by a team of ex-McKinsey and industry executives, AGMI combines strategic rigor with hands-on execution, focusing on four core areas: 1. R&D Portfolio Strategy & IND Readiness (Preclinical to Translational) 2. Commercial and Go-to-Market Strategy 3. Private Capital – Due Diligence & Equity Story Development 4. Operational Excellence & PMO Execution AGMI Group operates globally with hubs in Boston, Silicon Valley, and Puerto Rico, supporting clients across the U.S., LATAM, Japan, and Southeast Asia. Our team includes MDs, PhDs, and operators who bridge science and strategy, execution and insight—driving results where it matters most.